España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Viking Therapeutics
VKTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$42.25
0.76
1.83%
At close: -
$42.85
0.60
1.42%
After Hours: Dec 20, 7:58 PM EDT
Get Report
Comment
Viking Therapeutics (VKTX) Forecast
News
Earnings
Viking Therapeutics (VKTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Viking Therapeutics (NASDAQ:VKTX) Stock
Viking Therapeutics Stock (NASDAQ: VKTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 20, 2024
Looking Into Viking Therapeutics's Recent Short Interest
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Viking ...
Benzinga Newsdesk
Wednesday, December 18, 2024
What's Going On With Viking Therapeutics Stock On Wednesday?
Vandana Singh
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Smart Money Is Betting Big In VKTX Options
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Viking ...
Benzinga Newsdesk
Monday, December 16, 2024
9 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
Friday, December 13, 2024
"Weight-Loss Drug Craze Appears To Be Curbing...
Benzinga Newsdesk
Tuesday, December 10, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Thursday, December 05, 2024
Smart Money Is Betting Big In VKTX Options
Benzinga Insights
Tuesday, December 03, 2024
'ADA Advises Against Using Compounded GLP-1 R...
Benzinga Newsdesk
Monday, December 02, 2024
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Avi Kapoor
Piper Sandler Initiates Coverage On Viking Th...
Benzinga Newsdesk
Friday, November 29, 2024
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Surbhi Jain
Wednesday, November 27, 2024
HC Wainwright & Co. Reiterates Buy on Viking ...
Benzinga Newsdesk
Tuesday, November 26, 2024
HC Wainwright & Co. Reiterates Buy on Viking ...
Benzinga Newsdesk
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
Vandana Singh
Friday, November 22, 2024
How Is The Market Feeling About Viking Therapeutics?
Benzinga Insights
B. Riley Securities Initiates Coverage On Vik...
Benzinga Newsdesk
Wednesday, November 20, 2024
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs
Vandana Singh
Tuesday, November 19, 2024
Viking Therapeutics Presents Results From Pha...
Benzinga Newsdesk
Monday, November 18, 2024
What the Options Market Tells Us About Viking Therapeutics
Benzinga Insights
Friday, November 15, 2024
Shares of pharmaceutical and healthcare stock...
Benzinga Newsdesk
Market Whales and Their Recent Bets on VKTX Options
Benzinga Insights
Wednesday, November 13, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Tuesday, November 12, 2024
Viking Therapeutics To Present Data From Phas...
Benzinga Newsdesk
Tuesday, November 05, 2024
HC Wainwright & Co. Maintains Buy on Viking T...
Benzinga Newsdesk
Monday, November 04, 2024
Viking Therapeutics shares are trading lower....
Benzinga Newsdesk
Top 10 Trending Stocks On WallStreetBets As O...
Benzinga Newsdesk
Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety
Vandana Singh
Viking Therapeutics' VK2735 Shows Weight Loss...
Benzinga Newsdesk
Wednesday, October 30, 2024
Reported Earlier, 'Novo Nordisk's Ozempic and...
Benzinga Newsdesk
Tuesday, October 29, 2024
Unpacking the Latest Options Trading Trends in Viking Therapeutics
Benzinga Insights
Monday, October 28, 2024
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Benzinga Insights
Thursday, October 24, 2024
3 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Market-Moving News for October 24th
Benzinga Newsdesk
Viking Therapeutics shares are trading higher...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Viking ...
Benzinga Newsdesk
Wednesday, October 23, 2024
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
Vandana Singh
Viking Therapeutics Q3 2024 GAAP EPS $(0.22) ...
Benzinga Newsdesk
Tuesday, October 22, 2024
An Overview of Viking Therapeutics's Earnings
Benzinga Insights
Market Whales and Their Recent Bets on VKTX Options
Benzinga Insights
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
Surbhi Jain
Wednesday, October 16, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Friday, October 11, 2024
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
Vandana Singh
Thursday, October 10, 2024
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
Benzinga Insights
Wednesday, October 09, 2024
Viking Therapeutics Reveals Encouraging Data From Genetic Disorder Drug Study, Analyst Says Focus On Orphan Disease Broadens Viking's Potential Revenue Streams
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Viking ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch